THE SMART TRICK OF HEMGENIX THAT NOBODY IS DISCUSSING

Number of eligible patients: CDEC discussed the uncertainty in the amount of individuals with moderately severe to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific gurus consulted by CADTH indicated that some individuals who are classified as having moderate or reasonable condition might have a serious bleeding pheno